Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

ProPhase Labs (PRPH) Other Gross PP&E Adjustments (2016 - 2025)

Historic Other Gross PP&E Adjustments for ProPhase Labs (PRPH) over the last 15 years, with Q3 2025 value amounting to $2.4 million.

  • ProPhase Labs' Other Gross PP&E Adjustments rose 12967.5% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year increase of 12967.5%. This contributed to the annual value of $12.2 million for FY2024, which is 1845.53% up from last year.
  • As of Q3 2025, ProPhase Labs' Other Gross PP&E Adjustments stood at $2.4 million, which was up 12967.5% from $2.6 million recorded in Q2 2025.
  • ProPhase Labs' Other Gross PP&E Adjustments' 5-year high stood at $12.2 million during Q4 2024, with a 5-year trough of -$10.0 million in Q2 2024.
  • For the 5-year period, ProPhase Labs' Other Gross PP&E Adjustments averaged around $2.3 million, with its median value being $5.1 million (2021).
  • Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first plummeted by 17298.13% in 2023, then skyrocketed by 12967.5% in 2025.
  • Over the past 5 years, ProPhase Labs' Other Gross PP&E Adjustments (Quarter) stood at $6.5 million in 2021, then soared by 62.42% to $10.6 million in 2022, then decreased by 2.95% to $10.3 million in 2023, then rose by 18.46% to $12.2 million in 2024, then crashed by 79.96% to $2.4 million in 2025.
  • Its last three reported values are $2.4 million in Q3 2025, $2.6 million for Q2 2025, and -$5.9 million during Q1 2025.